Search

everythinglearnresearchcommunity

for

Search:↓

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

The document discusses various diseases of the outer ear, categorized by symptoms like redness, crusts, bumps, pus-filled lesions, lumps, ulcers, and hair loss.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

The document concludes that scalp health is influenced by complex factors affecting sebaceous glands, including hormones, aging, and various substances.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Topical PUVA can cause temporary hair regrowth in some alopecia areata patients but doesn't change the long-term outcome.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Finasteride can cause rare but serious skin rashes.

Transplant patients often get skin problems, with treatments varying by condition.

North American ginseng extract helped regrow hair in balding mice.